Suzhou Medsys Tech Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 2.81%

Suzhou Medsys Tech Co Ltd (603990) has an Asset Resilience Ratio of 2.81% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 603990 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥35.11 Million
≈ $5.14 Million USD Cash + Short-term Investments

Total Assets

CN¥1.25 Billion
≈ $182.68 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2017–2024)

This chart shows how Suzhou Medsys Tech Co Ltd's Asset Resilience Ratio has changed over time. See 603990 total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Suzhou Medsys Tech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Suzhou Medsys Tech Co Ltd stock valuation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥35.11 Million 2.81%
Total Liquid Assets CN¥35.11 Million 2.81%

Asset Resilience Insights

  • Limited Liquidity: Suzhou Medsys Tech Co Ltd maintains only 2.81% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Suzhou Medsys Tech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Suzhou Medsys Tech Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Alcidion Group Ltd
AU:ALC
Health Information Services 32.45%
DocCheck AG
XETRA:AJ91
Health Information Services 6.71%
Pro Medicus Ltd
AU:PME
Health Information Services 54.64%
Echoiq Ltd
AU:EIQ
Health Information Services 11.12%
ARTRYA Ltd
AU:AYA
Health Information Services 48.49%
Cogstate Ltd
AU:CGS
Health Information Services 54.90%
Oneview Healthcare Plc
AU:ONE
Health Information Services 29.71%
Singular Health Group Ltd
AU:SHG
Health Information Services 0.15%

Annual Asset Resilience Ratio for Suzhou Medsys Tech Co Ltd (2017–2024)

The table below shows the annual Asset Resilience Ratio data for Suzhou Medsys Tech Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 1.27% CN¥40.10 Million
≈ $5.87 Million
CN¥3.16 Billion
≈ $463.00 Million
-2.82pp
2023-12-31 4.09% CN¥160.06 Million
≈ $23.42 Million
CN¥3.92 Billion
≈ $572.93 Million
-1.31pp
2022-12-31 5.40% CN¥88.07 Million
≈ $12.89 Million
CN¥1.63 Billion
≈ $238.58 Million
-19.07pp
2021-12-31 24.47% CN¥321.14 Million
≈ $46.99 Million
CN¥1.31 Billion
≈ $192.04 Million
+24.80pp
2020-12-31 -0.33% CN¥-5.00 Million
≈ $-731.67K
CN¥1.52 Billion
≈ $222.67 Million
+0.43pp
2019-12-31 -0.76% CN¥-5.80 Million
≈ $-848.99K
CN¥760.27 Million
≈ $111.25 Million
-15.13pp
2017-12-31 14.37% CN¥90.00 Million
≈ $13.17 Million
CN¥626.50 Million
≈ $91.68 Million
--
pp = percentage points

About Suzhou Medsys Tech Co Ltd

SHG:603990 China Health Information Services
Market Cap
$709.03 Million
CN¥4.85 Billion CNY
Market Cap Rank
#10789 Global
#3179 in China
Share Price
CN¥15.82
Change (1 day)
+4.98%
52-Week Range
CN¥13.81 - CN¥17.71
All Time High
CN¥4534.27
About

Suzhou MedicalSystem Technology Co., Ltd. provides solutions in clinical informatics and digital hospital field in China. It offers DoCare anesthesia clinical information system that focuses on serving the perioperative clinical work; and provides streamlined, informational, automatic, and intelligent integrated management platform for clinical business. The company also provides DoCare intensive… Read more